Deadly flooding is hitting several countries at once. Scientists say this will only be more common Lethal flooding has simultaneously hit India, Japan, China, Turkey and the U.S. Northeast. Scientists have long warned that more extreme rainfall is expected in a warming world. AP News

...

All-species COVID-19 test can track disease in wild, domesticated animals - UPI.com Researchers can now detect the COVID-19 virus in any animal using a new all-species test. UPI

...

It's an advance that they say will help track COVID-19 variants in wild and domesticated animals.

..

What is known about the rare side effect 'Long Vax Syndrome'?

The phenomenon known as "Long Vax Syndrome" is gaining attention among researchers as they seek to better understand the potential side effects of the Covid-19 vaccine. Similar to the long-lasting symptoms experienced by some individuals with "Long Covid," Long Vax Syndrome is characterized by headaches, extreme fatigue, blood pressure issues, and abnormal heart rates that can persist for weeks or even longer. However, it is important to note that the number of reported cases of Long Vax Syndrome is significantly lower than the number of reported cases of Long Covid.

New study shows robust pandemic preparedness strongly linked to lower COVID-19 mortality rates The vast majority of countries that entered the COVID-19 pandemic with strong capacity to prevent, detect, and respond to disease threats achieved lower pandemic mortality rates than less prepared nations, ... Science X

...

The researchers sought to understand how different countries performed during the COVID-19 pandemic and how that relates to their pandemic preparedness capacity as measured by the GHS Index. ...

Revive Therapeutics' experimental COVID treatment fails in late-stage study Canada-based Revive Therapeutics said on Thursday its experimental COVID-19 treatment did not meet the main goal of a late-stage study. Reuters Reuters

...

Moderna seeks regulatory approval of RSV vaccine for people 60 and older - UPI.com Moderna has submitted its RSV vaccine for people 60 and older regulatory approval in the United States, European Union, Switzerland and Australia. UPI

...

Moderna said the regulatory applications come after positive data from a study of approximately 37,000 adults 60 or older in 22 countries. Its vaccine to protect from respiratory syncytial virus was found in these trials to be 83.7% effective as defined by two or more symptoms.

...